Oh Kyoung-suk, CEO of Dunamu, said there were "shortcomings" regarding the company's investment in Medistaff, which has been embroiled in controversy over obstructing residents' return to hospitals. Oh appeared as a reference witness at a National Assembly Health and Welfare Committee audit on the 15th and made the remark. Medistaff is a doctor community site, and Dunamu acquired an 18.29% equity stake this year for 4.3 billion won.
Han Ji-a of the People Power Party said that day, "As the medical-government conflict has dragged on, excess deaths (those who died because they could not receive proper treatment due to care gaps) totaled 3,136 from Feb. to Jul. last year," adding, "A key pillar preventing residents who wanted to return to hospitals from going back was Medistaff." Earlier, when residents collectively resigned over the conflict, some disclosed on Medistaff the personal information of colleagues who stayed at hospitals or returned.
Han said, "Posts such as 'If you go back (to the hospital), I will rape you' were also uploaded to Medistaff," adding, "The Medistaff operators enabled this by strengthening security so that the authors of such posts could not be identified and by letting them write with ease." She then asked, "What do you think about Medistaff's sense of ethics?" Oh said, "I am sorry for causing concern."
Han asked, "Did you invest while knowing that Medistaff abetted a medical community blacklist and that its operators were referred to prosecutors?" Oh said, "We invested to support the growth of a domestic medical platform," adding, "We reviewed it comprehensively, but as you said, it seems there were shortcomings." Han demanded that Oh submit the results of an assessment of the appropriateness of the Medistaff investment and a plan for action.